The company's team consists of experts in biochemistry, cell biology, physics, and engineering who design and build instruments for testing. D-Tails is focused on developing new biocompatible markers for detecting Tau aggregates in the retina, as well as mass screening tests for breast, prostate, and pancreatic cancers. Additionally, the company studies the specific behavior of C-elegans when exposed to VOCs and offers imaging solutions that include new super-resolution techniques, structured illumination, and adaptive optics.